Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug
Active, not recruiting · NCT05203679 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-04-01 | NCT05203679 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Xinzhi BioMed Co., Ltd. | 4 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | China | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College | Tianjin | China | 4 |
| Nanfang Hospital Southern Medical University | Guangzhou | China | 8 |
| North China University of Science and Technology Affiliated Hospital | Tangshan | China | 7 |
| Peking Union Medical College Hospital | Beijing | China | 19 |
| The second Affiliated Hospital of Kunming Medical University | Kunming | China | 2 |
| The Second Hospital of Shanxi Medical University | Taiyuan | China | 10 |
| The Second People's Hospital of Shenzhen | Shenzhen | China | 1 |